CHLORHEXIDINE HYDROCHLORIDE 0.1% AND NEOMYCIN SULFATE 0.5% (Naseptin®)
Clinical Indication
MRSA decolonization (to match current guidelines)
Comments
MRSA decolonisation for patients unable to tolerate mupirocin (Bactroban) and where mupirocin resistance is identified.
Date of classification
October 2023
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.